Oral terbinafine-induced plantar pustular psoriasis;Psoriasis pustuleux plantaire declenche par la terbinafine (Lamisil®)

Annales de Dermatologie et de Venereologie

Volumn 127, Issue 3, 2000, Pages 279-281

  Le Guyadec, T ^a   Saint Blancard, P ^b   Bosonnet, S ^a   Le Vagueresse, R ^b   Lanternier, G ^a  

^a Service de Dermatologie   (France)

^b Service d'Anatomie Pathologique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; TERBINAFINE; ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; ONYCHOMYCOSIS; PUSTULOSIS PALMOPLANTARIS; SKIN TOXICITY; BIOPSY; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; ORAL DRUG ADMINISTRATION; PATHOLOGY; PSORIASIS; SKIN; SKIN DISEASE;

ADMINISTRATION, ORAL; AGED; ANTIFUNGAL AGENTS; BIOPSY; DRUG ERUPTIONS; FOOT DERMATOSES; HUMANS; MALE; NAPHTHALENES; ONYCHOMYCOSIS; PSORIASIS; SKIN;

EID: 0034152336     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gupta AK, Sibbald RC, Knowless SR, Lynde CW, Shear NH. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation : four case reports and a review of drug-induced psoriasis. J Am Acad Dermatol 1997;36:858-62.
2. Gupta AK, Lynde CW, Lauzon CJ, Mehlmauer MA, Braddock SW, Miller CA, et al. Cutaneous adverse effects associated with terbinaflne therapy : 10 case reports and a review of the literature. Br J Dermatol 1998;138:529-32.
3. Dupin N, Gorin I, Djien V, Helal H, Zylerberg L, Leibowitch M, et al. Acute generalized exanthematous pustulosis induced by terbinafine. Arch Dermatol 1996;132:1253-4.
4. Papa CA, Miller OF. Pustular psoriasiform eruption with leukocytosis associated with terbinafine. J Am Acad Dermatol 1998;39:115-7.
5. Wach F, Stolz W, Rüdiger R, Hein R, Landthaler M. Severe erythema annulare centrifugum-like psoriatic eruption induced by terbinafine. Arch Dermatol 1995;131:960-1.
6. Wilson NJE, Evans S. Severe pustular psoriasis provoked by oral terbinafine. Br J Dermatol 1998;139:168.
7. Hall M, Monka C, Krupp P, O'Sullivan D. Safety of oral terbinafine. Results of a postmarketing surveillance study in 25884 patients. Arch Dermatol 1997;133:1213-9.
8. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985;40:111-4.
9. Schmutz JL, Malka N, Contet-Audonneau N, Reichert-Pénétrat S, Truchetet F, Barbaud A. Onychomycoses et psoriasis unguéal. Ann Dermatol Venereol 1998;125 (suppl 3):191.